Minulet - Dragees (Ethinylestradiol, Gestodene)

Ethinylestradiol / Gestodene, the active ingredient in Minulet, is a combined oral contraceptive presented as a dragee oral tablet for oral use. It delivers a fixed dose of estrogen and progestogen to reliably prevent pregnancy in women of reproductive age, offering a convenient once‑daily regimen for hormonal birth control.

GNH USA supplies Minulet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches that meet EU standards for combined oral contraceptives and adhere to stringent regulatory guidelines.

Minulet, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy. - Contraception (prevention of pregnancy): provides reliable birth control for women of child‑bearing age. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces menstrual discomfort. - Acne improvement: may lessen acne severity by modulating androgen activity in the skin.

Like all hormonal contraceptives, Minulet may be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild stomach upset. - Headache: tension‑type pain. - Breast tenderness: swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or heart attack. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Minulet, healthcare professionals should consider several precautionary measures to ensure safe use. - Contraindications: avoid in women with a history of thromboembolic disorders, estrogen‑dependent tumors, or uncontrolled hypertension. - Smoking: do not use in patients over 35 who smoke heavily, as cardiovascular risk increases. - Liver disease: use with caution in patients with hepatic impairment. - Medication history: review current use of enzyme‑inducing drugs that may reduce contraceptive efficacy. - Pregnancy testing: confirm non‑pregnant status before initiating therapy. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Minulet can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin, rifampicin): markedly reduce hormone levels, risking contraceptive failure. - Certain antibiotics (e.g., griseofulvin): may decrease contraceptive efficacy. - Antiretroviral protease inhibitors (e.g., ritonavir): can increase hormone concentrations, raising side‑effect risk.

Moderate Interactions (Monitor Closely): - St. John’s wort: may lower plasma hormone levels. - Antifungal azoles (e.g., ketoconazole): may increase hormone levels. - Diuretics and antihypertensives: may affect fluid balance and blood pressure.